Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit of Regulatory Alignment for Each Program Planned in 2026 New Research Supports TN-301’s Potential in Multiple Indications; Presented Preclinical Data for TN-301 in Duchenne Muscular Dystrophy Model Entered into Multi-Target Research Collaboration with Alnylam Pharmaceuticals December Financing with Net Proceeds of $55.8M and Anticipated Upfront Payment Extend Cash Runway into Second Half of 2027 SOUTH SAN FRANCISCO, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced financial results for the...

PLN-101095 Phase 1 data showed deep and durable ongoing responses in checkpoint inhibitor refractory solid tumors PLN-101095 accelerated development plan underway with initiation of Phase 1b indication expansion trial SOUTH SAN FRANCISCO, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, today provided a corporate update and reported fourth quarter 2025 financial results. “We ended 2025 with encouraging data from our lead oncology program in ICI-refractory patients, an area of unmet medical need, that informed the initiation of our accelerated development plan for PLN-101095,” said Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer of Pliant. “In addition to oncology and...

CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its second quarter and first six- months of fiscal year 2026.  Second Quarter Year to Date(in thousands, except per share amounts) Ended January 31, Ended January 31,  2026 2025 Change 2026 2025 ChangeConsolidated Results            Net Sales $ 117,737 $ 116,914 1 % $ 238,223 $ 244,859 (3)%Income from Operations * $ 15,693 $ 17,482 (10)% $ 32,647 $ 38,672 (16)%Net Income $ 12,569 $ 12,921 (3)% $ 28,025 $ 29,297 (4)%EBITDA † $ 21,735 $ 22,216 (2)% $ 45,376 $ 48,383 (6)%Diluted EPS – Common $ 0.87 $ 0.89 (2)% $ 1.93 $ 2.01 (4)%Business to Business            Net Sales $ 41,977 $ 43,416 (3)% $ 86,263 $ 91,831 (6)%Segment Operating...

CALGARY, Alberta, March 11, 2026 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) announces fourth quarter and year-end results for the period ended December 31, 2025. 2025 HighlightsCompleted the previously announced termination of the long-standing management agreement with Rife Management Ltd. (formerly Rife Resources Management Ltd.). Achieved record annual production of 16,294 boe/d, a 9% increase from 2024; Total annual crude oil and natural gas liquids production of 10,730 boe/d(1), a 12% increase from 2024; Generated total revenue of $313 million; Bonus and leasing revenue contributed $8 million, an increase from $3 million in 2024; Delivered $235 million in funds from operations ($1.43/share),(2)(4) a 2% increase from 2024; Returned $177 million ($1.08/share)(3) to shareholders through monthly...

FORT WORTH, Texas, March 11, 2026 (GLOBE NEWSWIRE) — HighPeak Energy, Inc. (“HighPeak” or the “Company”) (NASDAQ: HPK) today announced financial and operating results for the quarter and year ended December 31, 2025. In addition, HighPeak provided its 2026 guidance and capital budget, as approved by its Board of Directors. A statement from our President and CEO, Michael Hollis, “In light of the current geopolitical uncertainty and commodity price volatility, we are taking a disciplined and measured approach to 2026. Our priority is clear: protect profitability and maximize free cash flow, not chase production volumes. Our top financial objective is strengthening the balance sheet. Any incremental free cash flow generated in a stronger commodity price environment will be directed toward accelerating debt reduction. To strengthen...

MITCHEL FIELD, N.Y., March 11, 2026 (GLOBE NEWSWIRE) — Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM) is pleased to announce its financial results for the third quarter and fiscal year 2026. Revenue for the three and nine months ended January 31, 2026, was approximately $16.9 million and $47.8 million, respectively, compared to $18.9 million and $49.8 million, respectively, reported for the same period of fiscal year 2025. Operating income for the three and nine months ended January 31, 2026 was $1.3 million and $3.3 million, respectively, compared to $3.5 million and $8.5 million, respectively, reported for the same period of the previous fiscal year. Net Income from operations for the three and nine months ended January 31, 2026, was $1.6 million or $0.16 per diluted share and $4.0 million or $0.41 per diluted...

2025 full-year resultsRevenue: €786.4 million, down 3.5% at CER1 and like-for-like2, mainly due to the fall in activity in France Profitability: restated EBITDA margin3 of 12.0% (at the high end of the adjusted range communicated in December) Net Income: loss of €112.7 million, which includes a non-recurring impairment of €86 million Free cash flow: in positive territory at €19.2 million Indebtedness: net debt/EBITDA ratio of 4.0x, below the ceiling of 4.8x set in December 2025 under the waiver obtained by the Group from its lenders.2026Significant negative impact expected from the situation in Raleigh on revenue, profitability, cash generation and group indebtedness with a probable risk of covenant breach on June 30, 2026 No dividend distribution in respect of the 2025 fiscal year Continuation of the transformation plan and strategic...

PRESS INFORMATIONHeading: 2025 annual results        Nanterre, March 11, 2026 (after trading) Net profit, Group share stable in 2025Financial statements at December 31 (1) 2024 2025Revenues 810.4 857.2Business operating profit (2) 84.1 (10.4%) 82.1 (9.6%)Operating profit 77.9 (9.6%) 75.6 (8.8%)Financial profit/loss 10.2 9.5Income tax (24.9) (23.2)Net profit 63.2 (7.8%) 61.9 (7.2%)– of which, group share 52.5 52.1Free cash flow (3) 74.6 62.2Net cash net of financial debt (4) 319.5 336.6Staff at year-end 7,087 7,208(1)        In millions of euros, 2025 financial statements approved by the Board of Directors on March 11, 2026.(2)        Before cost of bonus shares(3)        Cash flow from operational activities, plus financial profit and less net industrial investments.(4)        Excluding IFRS16...

ANNUAL RESULTS FOR 2025Consolidated turnover: €160.3M, +2.1% (at constant exchange rate: +3.0%)EBITDA (1) = €18.7M, +13.0%Net Result = €6.8M, +11.8%Dividend = €1.0 per share, +4.2% Blagnac, France, March 11th, 2026, after closing of the Stock Market. SOGECLAIR, supplier of innovative solutions with high added value for a safer and less-consuming mobility publishes its financial results for the year ended December 31, 2025. SOGECLAIR is listed on Euronext Growth in Paris. The Board of Directors, which met on March 10th, 2026, has approved the financial statements for the year ended December 31, 2025. The audit procedures on the annual accounts have been carried out.All interim management figures improved, with EBITDA at 11.7% of turnover, increasing to €18.7 million, operating income at 6.4% of turnover, up significantly to €10.2 million,...

Sogeclair: annual results for 2025 (slideshow)AttachmentSOGECLAIR – SFAF 2025 RESULTS